Association between Galectin-13 Expression and Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease

References

• Agustí A, Celli B, Faner R. What does endotyping mean for treatment in chronic obstructive pulmonary disease? Lancet. 2017;390(10098):980–987. DOI:10.1016/S0140-6736(17)32136-0
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease: updated 2020. Available from: http://www.goldcopd.org.
   Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. DOI:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Soriano JB, et al. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study. Respir Res. 2022;23(1):49. DOI:10.1186/s12931-022-01965-3
   PubMed Web of Science ®Google Scholar
• Kostikas K, Brindicci C, Patalano F. Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD. Curr Drug Targets. 2018;19(16):1882–1896. DOI:10.2174/1389450119666180212120012
   PubMed Web of Science ®Google Scholar
• Antus B, Paska C, Barta I. Predictive value of exhaled nitric oxide and blood eosinophil count in the assessment of airway eosinophilia in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2025–2035. DOI:10.2147/COPD.S257965
   PubMed Web of Science ®Google Scholar
• Salazar F, Sewell HF, Shakib F, et al. The role of lectins in allergic sensitization and allergic disease. J Allergy Clin Immunol. 2013;132(1):27–36. DOI:10.1016/j.jaci.2013.02.001
   PubMed Web of Science ®Google Scholar
• Porębska N, Poźniak M, Matynia A, et al. Galectins as modulators of receptor tyrosine kinases signaling in health and disease. Cytokine Growth Factor Rev. 2021;60:89–106. DOI:10.1016/j.cytogfr.2021.03.004
   PubMed Web of Science ®Google Scholar
• Feng W, Wu X, Li S, et al. Association of serum galectin-3 with the acute exacerbation of chronic obstructive pulmonary disease. Med Sci Monit. 2017;23:4612–4618. DOI:10.12659/msm.903472
   PubMed Web of Science ®Google Scholar
• Sundqvist M, Andelid K, Ekberg-Jansson A, et al. Systemic galectin-3 in smokers with chronic obstructive pulmonary disease and chronic bronchitis: the impact of exacerbations. Int J Chron Obstruct Pulmon Dis. 2021;16:367–377. DOI:10.2147/COPD.S283372
   PubMed Web of Science ®Google Scholar
• Horio Y, Ichiyasu H, Kojima K, et al. Protective effect of galectin-9 in murine model of lung emphysema: involvement of neutrophil migration and MMP-9 production. PLoS One. 2017;12(7):e0180742. DOI:10.1371/journal.pone.0180742
   PubMed Web of Science ®Google Scholar
• Kono Y, Colley T, To M, et al. Cigarette smoke-induced impairment of autophagy in macrophages increases galectin-8 and inflammation. Sci Rep. 2021;11(1):335. DOI:10.1038/s41598-020-79848-0
   PubMed Web of Science ®Google Scholar
• Than NG, Balogh A, Romero R, et al. Placental protein 13 (PP13) – a placental immunoregulatory galectin protecting pregnancy. Front Immunol. 2014;5:348. DOI:10.3389/fimmu.2014.00348
   PubMed Web of Science ®Google Scholar
• Yi L, Zhang S, Feng Y, et al. Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma. Clin Exp Allergy. 2021;51(12):1566–1576. DOI DOI:10.1111/cea.13961
   PubMed Web of Science ®Google Scholar
• Compagno D, Tiraboschi C, Garcia JD, et al. Galectins as checkpoints of the immune system in cancers, their clinical relevance, and implication in clinical trials. Biomolecules. 2020;10(5):750. DOI:10.3390/biom10050
   PubMed Web of Science ®Google Scholar
• Nio-Kobayashi J. Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease. Anat Sci Int. 2017;92(1):25–36. DOI:10.1007/s12565-016-0366-6
   PubMed Web of Science ®Google Scholar
• Visegrády B, Than NG, Kilár F, et al. Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng. 2001;14(11):875–880. DOI:10.1093/protein/14.11.875
   PubMedGoogle Scholar
• Kawamatawong T, Apiwattanaporn A, Siricharoonwong W. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens. Int J Chron Obstruct Pulmon Dis. 2017;12:1625–1630. DOI:10.2147/COPD.S132132
   PubMed Web of Science ®Google Scholar
• Zhou W, Tan J. The expression and the clinical significance of eosinophils, PCT and CRP in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with pulmonary infection. Am J Transl Res. 2021;13(4):3451–3458.
   PubMed Web of Science ®Google Scholar
• Song W, Wang Y, Tian F, et al. Clinical significance of procalcitonin, C-Reactive protein, and interleukin-6 in helping guide the antibiotic use for patients with acute exacerbations of chronic obstructive pulmonary disease. Dis Markers. 2021;2021:8879401. DOI:10.1155/2021/8879401
   PubMed Web of Science ®Google Scholar
• Su L, Qiao Y, Luo J, et al. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. J Transl Med. 2022;20(1):76. DOI:10.1186/s12967-022-03278-x
   PubMed Web of Science ®Google Scholar
• Weissler JC, Adams TN. Eosinophilic chronic obstructive pulmonary disease. Lung. 2021;199(6):589–595. DOI:10.1007/s00408-021-00492-0
   PubMed Web of Science ®Google Scholar
• Li A, Chan HP, Gan PXL, et al. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma. Korean J Intern Med. 2021;36(6):1305–1319. DOI:10.3904/kjim.2021.180
   PubMed Web of Science ®Google Scholar
• Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J. 2007;29(5):906–913. DOI:10.1183/09031936.00146306
   PubMed Web of Science ®Google Scholar